Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

EU clears ChemChina takeover of Syngenta with conditions

Published 05/04/2017, 11:15
Updated 05/04/2017, 11:20
© Reuters. FILE PHOTO: Syngenta's logo is seen at Syngenta Biotech Center in Beijing
DOW
-
SYENF
-
DD
-

By Foo Yun Chee

BRUSSELS (Reuters) - ChemChina [CNNCC.UL] won EU antitrust approval on Wednesday for its $43 billion (34.45 billion pounds) bid for Swiss pesticides and seeds group Syngenta (S:SYNN), a crucial deal that could help China boost its domestic agricultural output.

The deal, the largest foreign acquisition by a Chinese company, is one of several that is reshaping the international market for agricultural chemicals, seeds and fertilizers even as they trigger fears among farmers that the pipeline for new herbicides and pesticides might slow.

Reuters reported on Feb. 2 that the deal would be cleared with conditions.

The European Commission said the asset sales addressed its competition concerns.

"It is important for European farmers and ultimately consumers that there will be effective competition in pesticide markets, also after ChemChina's acquisition of Syngenta," European Competition Commissioner Margrethe Vestager said in a statement.

Syngenta shares were trading up 1.5 percent after the EU's antitrust clearance was announced.

ChemChina will sell a large chunk of its subsidiary Adama's pesticide, herbicides and insecticides business, its seed treatment products for cereals and sugar beet and a substantial part of its plant growth regulator business for cereals.

Some of Syngenta's pesticides will also be put on the block. World No. 1 pesticides maker Syngenta sells its products in more than 90 countries under such brand names as Acuron, Axial, Beacon and Callisto. It sells seeds such as cereals, corn, rice, soybeans and vegetables.

U.S. antitrust authorities nodded the deal through on Tuesday on condition that ChemChina divest three products.

© Reuters. FILE PHOTO: Syngenta's logo is seen at Syngenta Biotech Center in Beijing

The EU approval came a week after it cleared the $130 billion Dow Chemical (N:DOW) and DuPont (N:DD) merger in return for hefty asset sales including global research and development facilities.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.